Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 2/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.41 |
| ▸ | LAP3 | P28838 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 3/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL1176955 | 0.92 | FDPS (0.40) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL28350800 | 0.92 | FDPS (0.40) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL27702165 | 0.92 | FDPS (0.40) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL29466464 | 0.90 | FDPS (0.39) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL28156330 | 0.90 | FDPS (0.39) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL16971219 | 0.82 | PTPN1 (0.37) | LAP3PTPN1FDPSALDH1A1TDP1 | |
| Phosphoric Acid SCHEMBL28701405 | 0.81 | LMNA (0.39) | LAP3PTPN1FDPSALDH1A1LMNA | |
| Phosphoric Acid SCHEMBL28906994 | 0.81 | LMNA (0.39) | LAP3PTPN1FDPSALDH1A1LMNA | |
| Phosphoric Acid SCHEMBL28149525 | 0.81 | LMNA (0.39) | PTPN1FDPSALDH1A1LMNATSHR | |
| Trolamine SCHEMBL691729 | 0.81 | KDM4C (0.37) | LAP3PTPN1FDPSLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107049957-A | The nano particle of encapsulating is prepared plant-scale | 伊休蒂卡有限公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-106727424-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106727477-A | The novel form of Diclofenac | 伊休蒂卡有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106420667-A | A novel formulation of diclofenac | 伊休蒂卡有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-102438592-B | Dosage forms of naproxen | 伊休蒂卡有限公司 | 2016-09-14 | — | — | CN | disclosed |
| CN-105663045-A | Production of encapsulated nanoparticles at high volume fractions | 伊休蒂卡有限公司 | 2016-06-15 | — | — | CN | disclosed |